Evidence map›Paper›PMID 39146355›Full record

ArticlePLoS medicine2024

Evaluation of person-centered interventions to eliminate perinatal HIV transmission in Kisumu County, Kenya: A repeated cross-sectional study using aggregated registry data.

Francesca Odhiambo, Raphael Onyango, Edwin Mulwa, Maurice Aluda, Linda Otieno, Elizabeth A Bukusi, Craig R Cohen, Pamela M Murnane

Abstract read
In one paragraph

Article in PLoS medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesca OdhiamboCentre for Microbiology Research, Research Care and Training Program, Kenya Medical Research Institute, Nairobi, Kenya.ORCID 0000-0002-3503-2294
Raphael OnyangoCentre for Microbiology Research, Research Care and Training Program, Kenya Medical Research Institute, Nairobi, Kenya.ORCID 0000-0002-6148-0218
Edwin MulwaCentre for Microbiology Research, Research Care and Training Program, Kenya Medical Research Institute, Nairobi, Kenya.ORCID 0000-0002-1932-3868
Maurice AludaCentre for Microbiology Research, Research Care and Training Program, Kenya Medical Research Institute, Nairobi, Kenya.
Linda OtienoCentre for Microbiology Research, Research Care and Training Program, Kenya Medical Research Institute, Nairobi, Kenya.
Elizabeth A BukusiCentre for Microbiology Research, Research Care and Training Program, Kenya Medical Research Institute, Nairobi, Kenya.ORCID 0000-0002-2031-2808
Craig R CohenDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
Pamela M MurnaneBixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0002-3773-5831

Funding

Sustainable Development for Improved HIV Health and Prevention in Kenya (SD4H-Kenya)D43TW011306 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUKUSI, ELIZABETH ANNE, COHEN, CRAIG R · 2020 to 2024
$1.9M
Implementing a risk score to facilitate enhanced adherence support for pregnant and postpartum women at risk of viremiaK01MH119910 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MURNANE, PAMELA MAE · 2019 to 2023
$922k
CDC HHS GH001947FIC NIH HHS D43 TW011306NICHD NIH HHS L30 HD089317NIMH NIH HHS K01 MH119910
6 · The paper itself

Abstract

backgroundFollowing a decline in perinatal HIV transmission from 20% to 10% between 2010 and 2017 in Kenya, rates have since plateaued with an estimated 8% transmission rate in 2021. Between October 2016 and September 2021, Family AIDS Care & Education Services (FACES) supported HIV care and treatment services across 61 facilities in Kisumu County, Kenya with an emphasis on service strengthening for pregnant and postpartum women living with HIV to reduce perinatal HIV transmission. This included rigorous implementation of national HIV guidelines and implementation of 3 locally adapted evidence-based interventions targeted to the unique needs of women and their infants. We examined whether these person-centered program enhancements were associated with changes in perinatal HIV transmission at FACES-supported sites over time. METHODS AND

findingsWe conducted a repeated cross-sectional study of annually aggregated routinely collected documentation of perinatal HIV transmission risk through the end of breastfeeding at FACES-supported facilities between October 2016 and September 2021. Data included 12,599 women living with HIV with baseline antenatal care metrics, and, a separate data set of 11,879 mother-infant pairs who were followed from birth through the end of breastfeeding (overlapping with those in antenatal care 2 years prior). FACES implemented 3 interventions for pregnant and postpartum women living with HIV in 2019: (1) high-risk clinics; (2) case management; and (3) a mobile app to support treatment engagement. Our primary outcome was infant HIV acquisition by the end of breastfeeding (18 to 24 months). We compared infant HIV acquisition risk in the final year of the FACES program (2021) to the year before intervention scale-up and following implementation of the "Treat All" policy (2018). Mother-infant pair loss to follow-up was a secondary outcome. Program data were aggregated by year and site, thus in multivariable regression, we adjusted for site-level characteristics, including facility type, urban versus rural, number of women with HIV in antenatal care each year, and the proportion among them under 25 years of age. Between October 2016 and September 2021, 81,172 pregnant women received HIV testing at the initiation of antenatal care, among whom 12,599 (15.5%) were living with HIV, with little variation in HIV prevalence over time. The risk of infant HIV acquisition by 24 months of age declined from 4.9% (101/2,072) in 2018 to 2.2% (48/2,156) in 2021 (adjusted risk difference -2.6% [95% confidence interval (CI): -3.7, -1.6]; p < 0.001). Loss to follow-up declined from 9.9% (253/2,556) in 2018 to 2.5% (59/2,393) in 2021 (risk difference -7.5% [95% CI: -8.8, -6.2]; p < 0.001). During the same period, UNAIDS estimated rates of perinatal transmission in the broader Nyanza region and in Kenya as a whole did not decline. The main limitation of this study is that we lacked a comparable control group.

conclusionsThese findings suggest that implementation of person-centered interventions was associated with significant declines in perinatal HIV transmission and loss to follow-up of pregnant and postpartum women.

Indexed as

HIV InfectionsInfectious Disease Transmission, VerticalRegistriesAdultCross-Sectional StudiesFemaleHumansInfantInfant, NewbornKenyaPatient-Centered CarePregnancyPregnancy Complications, InfectiousPrenatal CareYoung Adult

Identifiers

PMID39146355
PMCPMC11361728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.